ArrowMark Colorado Holdings LLC Has $7.82 Million Stake in Phreesia, Inc. (NYSE:PHR)

ArrowMark Colorado Holdings LLC decreased its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 9.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 343,206 shares of the company's stock after selling 37,809 shares during the quarter. ArrowMark Colorado Holdings LLC owned approximately 0.59% of Phreesia worth $7,822,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Trust Point Inc. lifted its position in Phreesia by 3.5% during the third quarter. Trust Point Inc. now owns 17,887 shares of the company's stock valued at $408,000 after acquiring an additional 607 shares during the last quarter. Ensign Peak Advisors Inc increased its stake in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company's stock valued at $477,000 after purchasing an additional 700 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company's stock worth $1,741,000 after buying an additional 853 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company's stock worth $637,000 after buying an additional 905 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its holdings in Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company's stock valued at $701,000 after purchasing an additional 1,120 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Insider Transactions at Phreesia

In other Phreesia news, insider Yvonne Hui sold 2,791 shares of the business's stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total value of $58,387.72. Following the completion of the transaction, the insider now directly owns 27,228 shares of the company's stock, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP David Linetsky sold 1,716 shares of the firm's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $39,897.00. Following the sale, the senior vice president now owns 203,318 shares in the company, valued at approximately $4,727,143.50. The trade was a 0.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 29,997 shares of company stock valued at $667,943. Company insiders own 5.80% of the company's stock.

Phreesia Trading Up 0.0 %

PHR stock traded up $0.01 during midday trading on Tuesday, reaching $21.11. The company had a trading volume of 110,579 shares, compared to its average volume of 444,554. Phreesia, Inc. has a 1 year low of $14.55 and a 1 year high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company has a 50 day moving average of $20.43 and a two-hundred day moving average of $21.84.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, beating analysts' consensus estimates of ($0.37) by $0.06. The business had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. As a group, equities analysts expect that Phreesia, Inc. will post -1.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the topic of a number of research analyst reports. Truist Financial boosted their target price on Phreesia from $29.00 to $31.00 and gave the company a "buy" rating in a research report on Friday, September 6th. Royal Bank of Canada reissued a "sector perform" rating and set a $23.00 target price on shares of Phreesia in a research note on Friday, September 27th. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird upped their price objective on Phreesia from $31.00 to $34.00 and gave the company an "outperform" rating in a research report on Friday, September 6th. Finally, JPMorgan Chase & Co. boosted their price target on Phreesia from $27.00 to $28.00 and gave the company an "overweight" rating in a report on Monday, September 9th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $29.42.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.